A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
Clinical trial NCT00002151 · COMPLETED
Trial details
- NCT number
- NCT00002151
- Sponsor
- Hoechst Marion Roussel
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.